DNA methylation can influence disease risk by altering gene expression. For example, hypermethylation of tumor suppressor genes can lead to their silencing and contribute to cancer progression. Conversely, hypomethylation of oncogenes can result in their activation. Understanding these patterns helps identify potential therapeutic targets and intervention strategies.
